Terns Pharmaceuticals, Inc.
TERN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89 | -$90 | -$60 | -$50 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16 | $26 | $11 | $8 |
| Change in WC | $4 | $1 | -$1 | -$1 |
| Other Non-Cash | -$2 | -$5 | $0 | $1 |
| Operating Cash Flow | -$70 | -$67 | -$49 | -$42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$170 | -$276 | -$140 | -$166 |
| Inv. Sales/Matur. | $158 | $238 | $118 | $47 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | -$38 | -$22 | -$120 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$13 |
| Stock Issued | $162 | $42 | $167 | $136 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | -$0 | $11 |
| Financing Cash Flow | $164 | $42 | $167 | $134 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $82 | -$63 | $96 | -$27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $80 | $143 | $48 | $75 |
| End Cash | $161 | $80 | $143 | $48 |
| Free Cash Flow | -$70 | -$67 | -$49 | -$42 |